Intra-Cellular Therapies's total assets for Q3 2024 were $1.32B, an increase of 0.30% from the previous quarter. ITCI total liabilities were $179.62M for the fiscal quarter, a 2.12% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.